chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Immediately, post vax, the pt became rigid with her eyes rolled back in her head and loss of consciousness. She was lifted to the floor in RN's lap. Vital signs stable. Circumoral pallor. Ammonia ampule used. Episode lasted approximately 1 minute with recovery after 30 minutes. Pt experienced nausea and headache. Resolved spontaneously.
Given 0.3 mls Pfizer vaccine instead of 0.2 ml Pfizer pediatric vaccine . No reaction/problems; no treatment required
Developed autoimmune inflammatory arthritis. Pain and swelling experienced in knees, wrists, and hands.
I ended up with mild stroke and a hospital stay, could not drive for three months. I also had to see a neurologist. I have trouble remembering things. I also feel tired and winded all the time.  I had all kinds of tests done at the hospital. I think it is coincidental, I do not feel like myself at all since the vaccine.
This spontaneous case reported by a nurse, describes the occurrence of administered expired product (318 patients received dose from vials beyond 30-day use by date) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 037C21A) for COVID-19 immunization. No medical history reported. On Jun 23, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Jun 23, 2021, patient administered expired product (318 patients received dose from vials beyond 30-day use by date). On Jun 23, 2021, administered expired product (318 patients received dose from vials beyond 30-day use by date) resolved. The reporter did not provide any causality assessments, concomitant medication or treatment information. Date of refrigeration of vial: May 7, 2021.
- Diagnosed with COVID-19  - extremely tired, achy, severe cough, sinus and chest congestion - over the course of 10 days, had very bad and very good days - Treated with OTC DayQuil, NyQuil, and Motrin; lots of fluids and rest
This spontaneous report as received from an unspecified reporter refers to a patient of unknown age and gender. On 11-FEB-2015 the patient was vaccinated with M-M-R II (route, dose, frequency and lot # not reported) which underwent an excursion (on an unspecified date). This is one of several reports from the same source. Additional information has been requested.
Pt stopped in Pharmacy 72 hrs after shot. Her right arm was very red and warm. The redness was at least 3 inches away from where the shot was given however I told her to call MD. Pt sopped in 48 hrs later. Rash resolved but MD started KEFLEX as precaution.
I've had a moderate head ache for five straight days that started shortly after getting the shot. I do not suffer from headaches normally. My vision seems to be slightly blurred but most of all I am suffering from dizzyness or vertigo which has been persistent and consistent. I feel like the ground is moving beneath me . This has not subsides for one minute since it started shortly after getting the shot .
joint pain; This is a spontaneous report from a non-contactable consumer (patient). A male patient of an unspecified age received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration on 10Feb2021 (Lot number was not reported) as dose number unknown, single for COVID-19 immunization.  The patient's medical history was not reported. There were no concomitant medications. The patient experienced joint pain on Feb2021. The outcome of the event was unknown. The event was reported as non-serious.   No follow-up attempts are possible. No further information is expected.
redness, warmth of inner upper right arm. warmth at injection site.Entire right upper arm (shoulder to elbow) painfull. Diagnosed as cellulitis.Clindomycin prescribed.
Pt reported she was woken up by a crushing pain to left elbow.  No redness, swelling, or temperature change at site of pain.  Pt reported she did feel chilled that night but did not have chills or fever.  Pt complained of tenderness to injection site with no redness or swelling.  Pt denies other symptoms post vaccine.
Abdominal pain, cramping, anorexia for 4 weeks since PO vaccination.
Severe hair disorder - complete loss of eyelashes & textural & structural changes, brittle, breaking and falling out by whole strands of head hair. Trying different shampoos & conditioners to no avail.
Red rash on neck area and on outside (left and right) corners of mouth. Patient stated her mouth was itchy. Pt. reported feeling dizzy.  School nurse documented pulse ox at time was 97 and heart rate was 91. Pt. ate a packed lunch from home around 11:15 am. Guardian was notified of symptoms by school nurse. Pt. was signed out of school by guardian and was advised by school nurse to seek medical evaluation with primary care. Pt. returned to school on the next day school was open which was 10/21/19.
I experienced soreness about 4 hrs. after shot lasting for just a couple days. After 10 days I got a rash and soreness returned...Covid Arm I understand. The rash went away after a couple days but my arm is still sore today, Mar. 2 almost 1 and 1/2 weeks later. I would like to know if the length of soreness is unusual and if I should be concerned about it getting better. I am scheduled for my 2nd shot in just a few days on Mar. 11.
pt recvd flu vax & exp burning & stinging @ the site of inject, characterized as much worse than last year; reaction lasted 1 wk;
high allergy blood count ,leg cramps, swelling on my calf, knee and foot, fluid on my right knee, unable to sleep at night due to the leg cramps. cramps in my hands
swelling of the lymph nodes; fever; right arm injection site pain; aches and pains; chills; This is a spontaneous report from a Pfizer-sponsored program via a contactable consumer (patient). A 53-year-old male patient received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL0140), intramuscular on 04Jan2021 at 13:00 at single dose in right shoulder for covid-19 prophylaxis. There were no medical history or concomitant medications. The patient experienced fever, right arm injection site pain, aches and pains, and chills on 05Jan2021, swelling of the lymph nodes on 06Jan2021. Event details: On 05Jan2021 in the morning, he started having a fever and chills. He stated that he noticed the injection site pain on the 05Jan2021 and stated that it only hurt at time of reporting if he pushed on it. He stated it did not hurt when he moved his arm around. The patient stated that he noticed the aches and pains on the 05Jan2021 in the morning and it stuck with him throughout the day and was over by the time he went to bed on 05Jan2021. Wednesday 06Jan2021, toward the early morning around 0300 under his arm hurt and the lymph node under his arm was swollen about the size of a baseball. The patient said that his fever was currently 99.5 in Jan2021. The outcome of events fever and swelling of the lymph nodes was not resolved, outcome of right arm injection site pain, aches and pains was resolved in Jan2021, outcome of event chills was unknown.
fevers from 100-101 beginning noc of vax cont x 6 days; pt was adm to hosp for r/o bacteremia & recvd ABT x 3 days
Broke out with shingles after 1st dose; This non-serious case was reported by a consumer and described the occurrence of shingles in a patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (above the gluteal fold ). Previously administered products included Acyclovir.   On 30-MAR-2023, the patient received the 1st dose of Shingrix. On 04-APR-2023, 5 days after receiving Shingrix, the patient experienced shingles (Verbatim: Broke out with shingles after 1st dose). The outcome of the shingles was not reported.   It was unknown if the reporter considered the shingles to be related to Shingrix.     It was unknown if the company considered the shingles to be related to Shingrix.   Additional Information: GSK Receipt Date: 10-APR-2023 The patient suffered from shingles at the hairline of head.  The patient previously had break out just above the gluteal fold and would take acyclovir as treatment. The patient was very surprised to had a breakout in hairline and asked was this normal for an outbreak to occur after getting the vaccine.
101.5 fever, nausea, dizziness, fatigue , headache, muscle aches, sore arm
DTaP#4 received (LA)- <24 hours after injection , arm from left shoulder to approximately 2 in above elbow very swollen and red.
First Anthrax on 2/13/2000, noting nausea, subjective fever/chills, myalgias/arthralgias and diarrhea for a couple of days. Today complaining of headache and mild nausea. Treat with Tylenol, as needed. After returning to work, had to go home from work because of headache (frontal pressure), mild light-headedness, nausea and vomiting x 1 this morning, fever and hot flashes, on 2/27/2000.
Pt would not take milk; Became very warm temp taken was 105; Taken to ER- temp 107; cooling methods administered;
On the morning of May 14/21, I was walking and all of a sudden my left foot went numb and I couldn't feel my foot stepping on the ground. The numbness went up my left leg while at the same time, my left hand started to go numb, starting at my baby finger and  working over to my thumb. I thought I might be having a stroke so I called my PCP and they recommended I go to the ER. There I was given a head CT and an MRI of my brain along with blood work. Everything came back normal.  I went home later that day and found I was extremely fatigued through the weekend. Then Tuesday morning  (05/18) I felt light headed and very unstable. I went back to the ER and another CT scan and MRI were done. Again both came back normal . I am currently wearing a ZIO heart monitor and I had an echocardiogram May 27, which also was normal. None of the doctors I spoke with were able to offer an explanation for my symptoms.
Sinus tachycardia, chest pain, extreme fatigue, shortness of breath and dizziness.
flushes - feeling hot on her chest as per patient;   BP=180/104;  HR=66, O2=96RA;   lungs-clear.  Hx-HTZ, increased cholesterol, hypothyroid.
At 10 days old my baby developed a congenital trigger finger.  I received the vaccine while I was approx 7 months pregnant with him.
feeling abnormal; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (feeling abnormal) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (feeling abnormal). At the time of the report, FEELING ABNORMAL (feeling abnormal) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication provided No treatment medication provided   This case was linked to MOD-2021-378200, MOD-2021-378201 (Patient Link).
This case was reported by a consumer and described the occurrence of injection site movement impairment in a subject of unspecified age and gender who was vaccinated with FLUARIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. On an unspecified date the subject received unspecified dose of FLUARIX (details unknown). At an unspecified time after vaccination with FLUARIX, the subject experienced injection site movement impairment and injection site discoloration. At the time of reporting the outcome of the events was unspecified. No further information was provided. This case was also reported as a pharmaceutical product complaint. The consumer reported a personal adverse event following FLUARIX vaccination (see case ID A0863089A). The consumer also reported that 3 other subjects at the same hospital where they received the vaccination experienced the same events. This is case 3 of 3, see case IDs A0863108A and A0863114A for the other reports. Follow-up received 18 June 2010: QA analysis revealed the complaint to be unsubstantiated.
Was diagnosed with pleurisy. Intense sharp chest pain while inhaling and exhaling. Have had it for one week, it has improved but is still painful.
Very tender, red knot on arm.  Became VERY hot, itchy, and and bumps on it two or three days after the 25th.  Looked like a red bullseye
Pt developed cellulitis was seen by pts MD 12/31 got antibiotics and recovered. Cellulitis was at site of ZOSTAVAX injection.
This is a spontaneous report received from a contactable physician. A female patient received unknown dose number of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. The patient experienced alopecia (lost hair on her head; it is growing back somewhat; her dermatologist said he's seen this a lot), with outcome of unknown. Additional information: The patient experienced hair loss at the top of her head, eyelashes and eyebrows after receiving the Pfizer-BioNTech COVID-19 vaccine. Reporter said their friend's dermatologist said he's seen lots of cases involving hair loss in many patients who had the COVID-19 vaccine. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Expired vaccine administered; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066F21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drug was reported. It was reported that vial that was expired on 03-Apr-2022 was administered to total of 24 patients including 15 males and 9 females. Health care professional reported administrations were mostly for booster shots. No side effects was reported. No treatment drug was reported.
Fevers on 5/18 (1 day after) up to 103 F and resolved on 5/19.  Severe chest and affected arm pain on 5/19 resolved on 5/20.
Presented to the Medical Center with concern for seizure activity, found to have atrial fibrillation in emergency department. Echocardiogram performed, and found to have moderately dilated left atrium and moderate mitral valve insufficiency. Initiated metoprolol for heart rate control, levetiracetam for possible seizure,  and rivaroxaban to prevent cardiac thrombosis.
Patient called the next day to report trouble breathing overnight - gasping for air, felt like her throat was closing. It subsided by the morning, but now she still has some tightness in her chest, body aches, a headache, and swollen eyes. Patient was advised to go to the ER if she had any trouble breathing.
was extremely sick; This is a spontaneous report from a Pfizer sponsored program via a contactable consumer (patient).  A male patient of an unspecified age received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. Medical history included cancer, congestive heart failure, chemo therapy. The patient's concomitant medications were not reported. The patient previously received the first dose of the same vaccine on an unspecified date for covid-19 immunization. The patient experienced extremely sick on an unspecified date and was unable to function for about a month- only the last few days have been able to function- sickest has ever been worse than chemo therapy-sickness was overwhelming. The outcome of the event was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Major bruising, fever, flu symptoms that lasted for two weeks. In 2016 a tumor (dermatofibroma) was found at the injection site. It had to be removed and tested for cancer.
sick for two weeks; Initial information received on 19-Nov-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-HCP.  This case involves an unknown age and unknown gender patient who became sick for two weeks after receiving influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received 1 DF (Dosage form) of suspect influenza vaccine produced by unknown manufacturer (with an unknown strength, formulation, frequency, route, expiry date, batch number, administration site) for prophylactic vaccination.   On an unknown date the patient developed a non-serious event sick for two weeks (illness) (unknown latency) following the administration of influenza vaccine.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event   Outcome was Unknown for the event sick for two weeks.
I had cough, fever, chills, body aches, loss of taste and smell. I was very weak and fatigued. My oxygen levels were low. These symptoms lasted about four or five days. I had the cough for a few weeks. I took a home COVID 19 test, positive result. Then I went to my doctor, took another COVID 19 test, positive results.
Injection site is still red 10 days after first dose; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA Vaccine; Lot number: EN6207), via an unspecified route of administration in the left arm on 18Mar2021 at 09:00 (at the age of 22-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food, or other products. Concomitant medications included drospirenone; ethinylestradiol (LORYNA), vitamin B12 (MANUFACTURER UNKNOWN), collagen (MANUFACTURER UNKNOWN), cetirizine hydrochloride (ZYRTEC), paracetamol (TYLENOL); all for unknown indications from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient had not been tested for COVID-19 since the vaccination. On 18Mar2021 at 10:00, one hour after vaccination, the patient experienced injection site redness which still exist 10 days after first dose. The patient did not receive any treatment for the event. The adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the vaccination site erythema was not recovered at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Pt developed oral thrush, constipation, diarrhea and lethargy. Pt had long term neurological damage. Child is dx'd with Heavy Metal Toxicity; Severe/Profound Autism. Requires 24 hour supervision. Seizure Disorder requires medication for Mental conditions/Severe/Profound Mental Retardation. Has been institutionalized for 10 years. Pt had MMR on 5/1/87. Follow up report received 12/19/02 states "I.Q.= 11, Adaptive Age 1.7, Chronological Age=16 years, 22 months, Generalized seizure disorder, Mood disorder, anxiety disorder, Nonverbal, severe/ profound Autism, Sleep Disorder, Patient has been institutionalized for 10+ years and will never live outside of an institution. Patient requires 24 hours supervision. Severely brain damaged."
1st dose Vaccine on Monday, super tired on Thursday; This is a spontaneous report from a contactable consumer (Patient). A 71-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot unknown reason=Not available/provided to reporter at the time of report completion), via an unspecified route of administration, administered in Left Arm on 25Jan2021 17:00 as SINGLE DOSE for covid-19 immunisation. If covid prior vaccination: No. If covid tested post vaccination: No. Known allergies: N/A. The patient medical history and concomitant medications was not reported. If other vaccine in four weeks: No, Other medications in two weeks: No. Facility type vaccine: School or Student Health Clinic. The patient experienced 1st dose vaccine on Monday, super tired on Thursday (fatigue) (non-serious) on 28Jan2021 13:00. If treatment AE: No. It was also provided as product=COVID 19, brand=Pfizer, lot unknown=False, administration date=25Jan2021, administration time=05:00 PM, dose number=2. The outcome of event was recovered on an unspecified date in 2021.  Information on batch/lot number was requested.
Started at 4 am body aches, headache , nausea, left arm super sore
Patient's symptoms began 24 hrs after administration of Pneumovax in the right deltoid. Patient had swelling and hives at the site of injection and moved upward to the top of the arm. Also had swelling in the lymph nodes in the right armpit area. Patient applied ice and took Benadryl for 2 days. Symptoms subsided.
pt recvd vax;fever of 105 occurred 24 hrs p/ vax accompanied by red,warm,swelling at rt deltoid;inject site (3" diam);fever & swelling resolved p/ 2 1/2 days;
sever chill and shivering.  minor fever around 100 degrees Farenheit
swelling in lymph nodes of neck; This case was reported by a consumer via call center representative and described the occurrence of lymphadenopathy cervical in a 57-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 10th September 2021, the patient received the 1st dose of Shingrix (intramuscular). On 11th September 2021, 1 days after receiving Shingrix, the patient experienced lymphadenopathy cervical. Shingrix was discontinued. On an unknown date, the outcome of the lymphadenopathy cervical was not recovered/not resolved.   It was unknown if the reporter considered the lymphadenopathy cervical to be related to Shingrix.     Additional Information: GSK Receipt Date: 31-Mar-2022 Reporter's comments: This case was reported by the patient's wife. Reporter did not have the lot or expiration date of the Shingrix vaccine administered. The patient received Shingrix in his right arm. The next day he developed swelling in the lymph nodes of his neck which was still unresolved. The patient's doctor advised patient not to get the second dose.The reporter did not consent to follow-up. The reporter did not gave consent to contact patient's healthcare professional.
fever 99.1 degrees Fahrenheit/temperature was 100.3 degrees Fahrenheit; aching all over; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever 99.1 degrees Fahrenheit/temperature was 100.3 degrees Fahrenheit) and MYALGIA (aching all over) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced PYREXIA (fever 99.1 degrees Fahrenheit/temperature was 100.3 degrees Fahrenheit) and MYALGIA (aching all over). At the time of the report, PYREXIA (fever 99.1 degrees Fahrenheit/temperature was 100.3 degrees Fahrenheit) and MYALGIA (aching all over) outcome was unknown.            No concomitants were reported. No treatment medication was reported.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable